We understand and appreciate the complexities involved in sourcing the most appropriate medication. We use our science-based approach, operational expertise and global experience to effectively, ethically and efficiently specify, source and supply comparators and devices.
We use our science-based approach, operational expertise, and global experience to effectively, ethically, and efficiently specify, source, and supply comparators and devices.
Vanessa started her career as a research associate at Scotland Yard and then joined LGC Group. Subsequently, she joined IQVIA where she worked with some of the largest biopharmaceuticals and biotechs to provide innovative solutions.
She has extensive experience in drug development from preclinical to registration and commercialisation strategies. She has secured product registration for several orphan and first-in-class drugs. She was also Chief Commercial Officer in a leading technology provider for patient access to clinical trials.
Vanessa was Senior Advisor to DiGamma Capital. She is on the Enterprise Advisory Board of CW+ and undertakes extensive charity work. She has a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge and a Masters Degree in Market Access from the University of Lyon.
Cesar worked in many blue-chip companies before joining CSI. Namely, he worked at Procter & Gamble as a European Supply Manager, Coca-Cola as a Business Analyst and Archimedes Pharma. At Parexel International, Cesar was in Global Category Sourcing with a focus on procurement, project management of global studies, stock management and financial analysis.
He is very knowledgeable in modelling supplies to ensure minimum wastage, supply/demand planning, regulatory requirements specific to drug distribution, project management of multiple vendors and delivering comparators to global studies on time and budget.
Cesar has a Bachelor’s and a Masters Degree in Chemical Engineering and a Diploma in Management studies.
Maurizio has over 30 years’ experience in investment banking. He has interests and expertise in healthcare and a keen eye for early-stage innovative biotech and medtech companies.
Maurizio was on the Board of Molmed SpA, listed in Milan, and on the Board of Lay Line Genomics. Before joining CSI, he was a Financial Advisor of San Raffaele Hospital, Milan, and a Fund Manager of Luxembourg SICAV (Long-Short Strategy European stocks).
He started his career as Head of New Issues, Schroders, and subsequently Managing Director, Capital Markets, Citigroup. He is an Honorary Member of the Italian Medical Society of Great Britain. Maurizio earned his BSc in Anthropology from UCL, and Masters Degree in Economics from LSE.
William has a Bachelor’s degree in Biological Sciences from Durham University and a Masters in Global Health and Development from University College London. At Durham, he specialised in molecular and cellular biology with a specific interest in Immunology and Oncology. At UCL, he applied this scientific expertise to gain a more holistic understanding of the pharmaceutical and healthcare sector with an emphasis on the pricing structure of global markets and country-level legal requirements.
William is an ex-rugby player, second raw and rowed at a competitive level for many years; he now coaches juniors at his local club at Henley. William applies his competitive spirit to find outstanding solutions for our clients. Between his undergraduate and postgraduate degrees, William spent a year working on sea turtle conservation projects based in Greece and Thailand.
Vasia is an APMG Certified Project Director, with more than 15 years’ experience working in complex management environments. Vasia started her career at St Thomas’s Hospital where she worked as a Research Associate and Patient Liaison Manager. Subsequently, she was a Director at the Gates Foundation and led a global, multi-centre HIV Vaccine Discovery Consortium. Vasia has extensive experience and expertise in drug discovery, clinical trials, matrix driver performance management and multiple vendor management.
She is an Innovation Business Partner at the Chelsea and Westminster Hospital NHS Trust. Vasia brings unique expertise into all quality-related matters of complex projects in a drug development environment and is responsible for overlooking quality and compliance at CSI. Vasia has a BSc in Biochemistry and an MSc in Molecular Medicine from UCL.
Dimitra has a First Class, Dean’s List Degree in Biomedical Science from the University of Essex and a Masters in Pharmaceutical Formulation and Entrepreneurship from UCL. Her expertise is in drug interaction and formulation along with an emphasis in regulatory framework requirements.
She has undertaken several research-based projects involving cell breakage, ELISA, immunoassays, spectroscopy, enzyme assays, protein purification, gene cloning, UV analysis, HPLC and microscopy, and PCR and real-time PCR.
Her solid scientific background allows Dimitra to critically evaluate requirements and offer science-based solutions. Dimitra plays basketball on an international level for her national team and also mentors young athletes.
Kotaro has been in Investment Banking businesses over 23 years. He has worked with pharmaceutical manufactures and grown his interests in biochemicals and meditechs as well through the investment banking business activities.
He started his career in Tokyo as a retail sales branch manager then expanded his expertise to wholesale and internationally in Amsterdam and London within the industry. He also worked for Sony Corporation at the global headquarters in Tokyo in 1998 and joined staring-up an online brokerage firm. During his position at Deutsche Bank AG London in the Global Market Division for nearly 10 years since 2003, he obtained the Leave to Remain in the UK VISA to become a local employee. He supported major listed Japanese Pharmaceutical companies and also many related firms in the industry through supporting their Investor Relations activities from London not just in the UK and Europe region but globally.
He has cultivated his career diversified in ESG (Environmental, Social and Governance) area and organized a Japan featuring ESG conference with the Financial Times in London in 2019.
He has a bachelor degree of Social Science and Economics at Waseda University.
Peter started his career in clinical trial logistics for a leading life sciences specialist, Marken before joining CSI. At Marken he developed extensive experience in the distribution of high-value and time-critical IMP and commercial drugs, Cell & Gene manufacturing material, biological samples, and coordinated the setup and management of Direct-to-Patient studies across Europe – many during the COVID-19 pandemic outbreak.
In addition, he also has expertise in cold chain packaging and import/export regulatory requirements to advise and provide the most robust and efficient solution to clients no matter the challenge.
Peter is a qualified BCU Canoeing instructor and holds a Bachelor’s Degree in Computer Visualisation and Animation.
Srikanth has more than 10 years’ experience in pharmaceutical industry as a Quality Assurance professional. He has worked for some leading pharmaceutical companies; Sanofi, GSK and MSD implementing and executing quality procedures for variety of dosage forms infusions, solid dosages, medical devices, and consumer health care products.
He has hands on experience in managing the quality systems compliant to MHRA, EU-GMP and US FDA guidelines. He is very knowledgeable in vendor audits, project management, managing the quality systems such as Change controls, Risk assessments, investigating customer complaints and deviations. He is responsible for our Quality Management System and for CSI being always audit ready!
He is a passionate shuttle badminton player and a keen runner. Srikanth has bachelor’s and master’s degree in Analytical Chemistry.
Steve is a veteran of the pharmaceutical industry having started his career at Pfizer in research, development and formulation of novel compounds. Subsequently, he worked as Head Pharmacist in some of the largest NHS Trust Hospitals in the UK where he gained invaluable experience in stock control, manufacturing, clinical trials and validation procedures.
Steve moved back to the Pharmaceutical and Manufacturing Industry and has extensive expertise in all aspects of site quality and regulatory compliance, (MHRA and ISO), third party EUGMP audits, QP product release on MIA (IMP) license, Responsible Person and Quality Controller.
Steve is a Member of the Royal Pharmaceutical Society of Great Britain, Member of the General Pharmaceutical Council and Member of the Joint Pharmaceutical Analysis Group. Steve is a qualified Pharmacist B.Pharm. (Hons) and has a Diploma in Psychiatric Pharmacy.
We are always seeking the most innovative scientific talent to join our team. Please get in touch
Put our team to the test. Request a callback and we'll contact you right away.